Management of low-risk prostate cancer.

Management of low-risk prostate cancer.

Bibliographic Details
Main Authors:	Gardiner, R, Hamdy, F
Format:	Journal article
Language:	English
Published:	2008

Similar Items

THE ROLE OF ACTIVE MONITORING IN THE MANAGEMENT OF PROSTATE CANCER
by: Hamdy, F
Published: (2009)

Early diagnosis and surgical management of prostate cancer.
by: Linton, K, et al.
Published: (2003)

[Early diagnosis and surgical management of prostate cancer]
by: Linton, D, et al.
Published: (2004)

Early diagnosis and surgical management of prostate cancer
by: Linton, D, et al.
Published: (2004)

Staging in prostate cancer.
by: Wilkinson, B, et al.
Published: (2002)

Screening for prostate cancer: an update.
by: Bryant, R, et al.
Published: (2008)

Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?
by: Hamdy, F
Published: (2005)

Prostate cancer: screening approaches.
by: Donovan, J, et al.
Published: (2005)

Prostate cancer: screening approaches
by: Donovan, J, et al.
Published: (2005)

Long-term quality of life in prostate cancer.
by: Hamdy, F
Published: (2011)

Long-term quality of life in prostate cancer
by: Hamdy, F
Published: (2011)

The prostate cancer prevention trial and its messages.
by: Hamdy, F
Published: (2007)

Novel biomarkers for the detection of prostate cancer
by: Jakobsen, N, et al.
Published: (2017)

Three dimensional ultrasound and prostate cancer.
by: Mehta, S, et al.
Published: (2004)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
by: Vickers, A, et al.
Published: (2010)

Endothelin and skeletal metastases in hormone-refractory prostate cancer
by: Hamdy, F
Published: (2003)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
by: Macefield, R, et al.
Published: (2009)

Screening for prostate cancer. The case against.
by: Donovan, J, et al.
Published: (2005)

Screening for prostate cancer remains controversial.
by: Neal, D, et al.
Published: (2009)

Screening for prostate cancer: views from the UK and the rest of the world
by: Hamdy, F
Published: (2003)

10-year outcomes in localized prostate cancer.
by: Hamdy, F, et al.
Published: (2017)

Curative radiation therapy in prostate cancer.
by: Harmenberg, U, et al.
Published: (2011)

First report of prostate-specific membrane antigen-targeted immunotherapy in prostate cancer: the future is bright
by: Lamb, A, et al.
Published: (2018)

Identification of new genetic risk factors for prostate cancer.
by: Guy, M, et al.
Published: (2009)

Metabolic imbalance and prostate cancer progression.
by: Burton, A, et al.
Published: (2010)

Imaging proteolysis in prostate cancer and stromal cells
by: Molokwu, C, et al.
Published: (2007)

The spectrum of prostate cancer care: From curative intent to palliation
by: Ali, A, et al.
Published: (2008)

Time for a “radical” change to active surveillance for prostate cancer?
by: Donovan, J, et al.
Published: (2018)

The spectrum of prostate cancer care: from curative intent to palliation.
by: Ali, A, et al.
Published: (2007)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
by: Shui, I, et al.
Published: (2014)

Vasectomy and the Risk of Prostate Cancer COMMENTS
by: Goldacre, M
Published: (2008)

Familial risk of prostate cancer in Iceland.
by: Eldon, B, et al.
Published: (2003)

Orient expression: solving the mystery of Asian prostate cancer?
by: Lamb, A, et al.
Published: (2017)

Diagnostic pathways for screen-detected prostate cancer: The plot thickens
by: Hamdy, F, et al.
Published: (2017)

The Prostate Testing for Cancer and Treatment (ProtecT) study: what have we learnt?
by: Hamdy, F
Published: (2017)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
by: Hamdy, F, et al.
Published: (2006)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
by: Hamdy, F, et al.
Published: (2006)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium
by: Shui, I, et al.
Published: (2014)

Markers of bone turnover and disease status in prostate cancer
by: Hannon, R, et al.
Published: (2003)

The role of osteoprotegerin in breast and prostate cancer
by: Holen, I, et al.
Published: (2002)